As a highly reactive reagent widely used in pharmaceutical synthesis, sec-butyllithium has long been limited by four major challenges: safety risks, scale-up bottlenecks, storage and transportation hazards, and reaction and quenching risks. Due to its high reactivity and associated hazards, the use of sec-butyllithium is strictly restricted by many companies, making large-scale industrial application particularly difficult.

Leveraging continuous flow technology as its core platform, PharmaBlock has addressed the fundamental challenges of sec-butyllithium application through innovations in reaction control, scale-up implementation, and enabling technologies.

Precise Control of Reaction Risks
Through continuous flow microreaction technology, reaction temperature, residence time, and material ratios are precisely controlled, eliminating localized overheating and uneven mixing commonly encountered in traditional batch processes. This significantly improves reaction selectivity and yield while mitigating the high reactivity and runaway risks associated with sec-butyllithium.

Scalable Manufacturing
By utilizing the inherent scalability of continuous flow processes, laboratory-scale results can be smoothly transferred to hundred-kilogram-scale production. This approach avoids the parameter drift and quality variability often observed during batch-process scale-up, providing a practical pathway for the industrialization of highly reactive reagents.

Breakthroughs in Core Technologies
Dedicated DTR equipment is employed to address mass-transfer limitations and pipeline blockage issues encountered in heterogeneous solid–liquid–gas reactions under ultra cryogenic conditions. Combined with online quenching technology, heat generation and hydrogen evolution are precisely controlled, establishing a robust safety barrier throughout the entire process.

Building on this technological foundation, PharmaBlock has also established an inherently safer production system. To address the key characteristics of sec-butyllithium, namely its sensitivity to moisture and oxygen, as well as its flammability and explosive potential, the company has developed a comprehensive, multi-layered safety management framework.

Full-Process Risk Control
A direct pump-transfer mode minimizes exposure and handling risks associated with highly reactive reagents. This is supported by triple interlock alarm systems for feed, temperature, and pressure control, as well as automated shutdown, venting, and cleaning systems that mitigate safety risks at the source.

Real-Time Safety Monitoring
AI-based fire source identification, 24/7 real-time monitoring, and routine on-site inspections provide continuous safety oversight. In addition, a rapid-response supply chain enables low-inventory handling and transfer of highly reactive reagents, reducing storage, transportation, and operational risks.

Multi-Dimensional Safety Management
Comprehensive pre-production risk assessments are conducted jointly by multiple departments. An independent explosion-proof production area and dedicated fire-protection systems have been established, while equipment undergoes secondary verification and rigorous safety inspections. Together, these measures create an inherently safe system across the entire production lifecycle.

Through the integration of process innovation, system control, and on-site verification, PharmaBlock has successfully established a core technological platform for the continuous flow application of highly reactive reagents. These achievements can be replicated across additional projects, providing strong support for the sustainable growth of the company's business.

This breakthrough removes key barriers to the large-scale industrial application of sec-butyllithium and provides a safe, efficient, and standardized solution for high-solids-content reactions in pharmaceutical synthesis. It further demonstrates PharmaBlock's technical expertise and end-to-end safety management capabilities in the field of highly reactive reagents, setting a new benchmark for process innovation and industrial upgrading.